Making a difference to our communities

We strive to serve the evolving needs of the society and contribute to the overall health and wellness of our world. We are building partnerships in communities throughout the world to strengthen health systems, increase access to our medicines, and find sustainable solutions to the health challenges of today, and tomorrow.

Our CSR Purpose

Pfizer Limited stays committed to its purpose Breakthroughs that change patients’ lives by

Nurturing innovations to expand the reach of quality healthcare,

Encouraging colleagues to engage in community development, and,

Synergizing efforts in partnerships with Government and other stakeholders for collective impact.

Pfizer Limited CSR priorities

  • Encourage Indian healthcare innovation and intellectual property
  • Support national programs and priorities with linkages to healthcare
  • Develop community outreach initiatives involving colleagues
  • Create patient awareness and access programs
  • Contribute to disaster relief work

India CSR initiatives gain momentum

Pfizer Limited’s CSR initiatives are carefully selected to ensure they are novel, scalable and sustainable, while also aligning with our global imperative to be recognized by society as a good corporate citizen. These initiatives are assessed on their approach and ability to address a key healthcare priority, originality, sustainability and scalability. By focusing our attention and committing resources to projects that meet each of these parameters, our CSR initiatives are designed to ensure maximum benefit to communities.

Ongoing CSR Initiatives for the year

Cancer Care initiative

India bears a significant burden of Cancer with limited health system infrastructure, a scarcity of oncology specialists and patients’ inability to afford cancer treatment. This led to the launch of Pfizer Ltd’s Cancer Care initiative in partnership with Alamelu Charitable Foundation (ACF)—a SPV constituted by Tata Trusts. The project’s aim is to serve as a one-stop, information and support program for patients and families at key cancer facilities supported by Tata Trusts.

The program is in the first Phase of its operation and includes the following:

a. Health and Wellness Kiosks in Ranchi, Diphu, Silchar and Tirupati. These kiosks provide services including counselling and interactive sessions on preventing cancer and other lifestyle-related disorders, counselling sessions for smoking cessation and prevention, screening for Oral, Cervical and Breast cancer and general physician examinations among others.

b. Community Outreach and early detection for NCDs through screening of catchment populations and referral to nearest centres.

c. Set-up and operationalise a Patient Referral and Tracking Platform.

d. Manage and operate a Virtual Patient Helpdesk, complemented by one-on site patient navigator in OPD and day care centers in Ranchi, Diphu, Silchar and Tirupati.

COVID-19 relief efforts in India

While globally, Pfizer is leading the effort to discover therapeutics and vaccines to counter COVID-19, Pfizer Ltd. is also actively supporting the relief efforts here in India through our Corporate Responsibility platforms. Pfizer Ltd. has deployed an estimated Rs. 2.5 crore towards various COVID-19 relief efforts.
Some of the key interventions include:

Donation of 3 lac protective N95 Masks

Our frontline healthcare workers are performing a remarkable duty to provide healthcare services to patients across the country. In order to provide relief to such personnel, Pfizer Ltd. funded NGOs to donate close to 3 lac N95 protective masks for use by frontline and supporting healthcare personnel across India.

Providing 5 State-of-the-art ventilators

As the number of COVID-19 cases rapidly increased in Maharashtra, the MCGM Disaster Management Cell along with the Health Department ramped up the testing and isolation facilities available. Pfizer partnered with Americares India Foundation to provide five high-quality Macquet Servo-I Ventilators to three key Government hospitals with COVID-19 facilities: HBT Trauma Care Centre, Jogeshwari; Bhabha Hospital, Bandra; and Rajawadi Hospital, Ghatkopar, all located in densely populated suburbs in Mumbai.

Assisting migrant workers with food relief

Goa is home to Pfizer’s manufacturing plant. Being an industrial state, it is also home to a large migrant population that would require basic food relief and support at this time. Through its NGO partners, Pfizer provided food and grocery packets and other essentials for those in need in the talukas of Sattari and Valpoi in Goa.

COVID-19 Treatment Facility for Police Personnel

In addition to the healthcare workers, our police personnel too are serving as COVID Warriors with courage and dedication. In order to support our Police Personnel, Pfizer supported a 75-bed isolation ward at the Mumbai Police Kalina Hospital for the Maharashtra Police. Support was provided towards COVID-19 Emergency Response Intervention for setting up of the temporary COVID-19 hospital dedicated to police personnel in Kalina and critical lifesaving supplies.

Essential medicine donation

The company donated 75,000 tablets of Trulimax (Azithromycin), responding to a call from the Government of India for the treatment of COVID-19 patients under the care of Government facilities.

In addition to Pfizer Ltd. efforts, Pfizer Inc., through the Pfizer Foundation, has also supported COVID-19 relief efforts in India. These include:

Supporting Quarantine Facilities at Dharavi in Mumbai

Dharavi had emerged as an epicenter of COVID-19 outbreak in Mumbai. The Government responded by stepping up its effort in setting up a quarantine facility to contain and control further spread of the disease. Pfizer supported the MCGM’s efforts in setting up this facility by supporting critical care lifesaving equipment for COVID-19 patients and the frontline healthcare staff with critical protective gear.

Donation of N95 Masks

Supplementing Pfizer Ltd.’s efforts, Pfizer Foundation additionally funded donation of almost 1 lac masks for use by frontline healthcare workers across 17 cities in India.

Pfizer-IIT Delhi Innovation & IP Program

Pfizer Ltd created this unique incubation accelerator program with an aim to support, promote and reward healthcare innovations made in India. Through this Program, Pfizer Ltd. supports incubation and IP filing of start-ups with promising ideas in the field of healthcare that can truly add value to healthcare delivery in the country. The program, launched in partnership with the Foundation for Innovation and Technology Transfer (FITT) at IIT Delhi, is now in its fourth phase. Since inception in 2015-16, collectively between full-time incubations and support for IP filings, the program has supported 34 innovators in their journey of creating innovations.

Combat India’s AMR Challenge

Pfizer Ltd. continues to focus on one of the most pressing healthcare challenges of our times – the growing menace of anti-microbial resistance. A dangerous phenomenon that makes antibiotics and other drugs ineffective against disease causing pathogens. After a successful launch of a high-decibel public awareness campaign ‘AMR ko Aao Milkar Rokein’ (Let us work together to curb AMR) in January 2019, Pfizer continued its efforts to curb AMR in India. With a clear priority to “Support national programs and priorities with linkages to healthcare”, Pfizer Ltd, in March 2020, partnered with an NGO Americares India Foundation (AIF) to roll out two distinct initiatives that aimed at reducing the spread of antimicrobial resistance in the country.

A flagship programme under this umbrella—Project Parivartanfocusses on addressing the current Infection Prevention and Control (IPC) challenges in healthcare facilities. In this multi-year project, Pfizer will support the development of a model for “Institutional Capacity Building” to deliver facility-based IPC and Anti-Microbial Stewardship (AMS) among small and mid-size hospitals across India. The goal is to demonstrate a tangible impact of infection prevention and antimicrobial stewardship activities on key outcome indicators of hospitals, such as a reduction in hospital acquired infections.

Additionally, Pfizer along with AIF, will launch an Online Learning Platform for healthcare workers to ensure that they have access to quality training on IPC across India. The project is currently in the initial phase of building the IPC module as per the WHO guidelines. The platform would be accessible free of cost with certification in three languages (English, Hindi, Malyalam).

Village Transformation Project

Pfizer Ltd., in partnership with BAIF, has embarked on a holistic village transformation intervention. The aim of the project is to transform lives of the 5000 people living in 13 hamlets of Kualale gram panchayat at Jawhar, Maharashtra, adopted by Pfizer. The objective of the program is to:

  • Improve access and availability of drinking water all-round the year
  • Ensure access to nutrition, sanitation and healthcare facilities.
  • Improve livelihood options through an increase in productivity and diversification
  • Create awareness regarding water and water conservations

With these interventions, we hope to build sustainable, productive, healthier and self-sufficient communities in the region.

Pfizer Global    SITEMAP | CONTACT US   
Copyright © 2009 Pfizer Limited, India. All rights reserved. Bookmark this page | Feedback | Privacy Policy | Terms of Use
The product information provided in this site is intended only for residents of India. The products discussed herein may have different product labeling in different countries.
Site best viewed in Internet Explorer 5.5 + & Netscape Navigator 7.0 + with screen resolution of 1024 x 768 pixels.